CYBERDYNE Inc.
Stock Price Chart
2026/07/30 UpdatedPrice Trend
2026/07/30 UpdatedPrice & Trading Details
2026/07/30 UpdatedPRICE
TRADING
Analyst Recommendations 2 analysts
Updated 2026/07/01Earnings Calendar
Updated 2026/07/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2021/05/14 | ¥0.70 | ¥-0.65 | -192.9% |
| 2021/02/12 | ¥0.30 | ¥-0.40 | -233.3% |
Shareholder Composition
Updated 2026/07/01Major Holders
Updated 2026/07/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
SPDR INDEX SHARES Fd.S-State Street SPDR S&P Intl Small Cap ETF
|
78.2K | -2.01% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-World ex U.S. Core Eqy. PORT.
|
45.6K | 0.00% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-Dimensional VA Intl Small PORT.
|
12.0K | 0.00% |
Financial Performance
2026/07/26 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥3,289M | ¥4,354M | ¥4,384M | ¥3,846M |
| Gross Profit | ¥1,791M | ¥2,393M | ¥2,373M | ¥2,265M |
| Operating Income | -¥1,146M | -¥2,018M | -¥926M | -¥601M |
| Pretax Income | ¥246M | -¥659M | -¥576M | ¥862M |
| Net Income | -¥298M | -¥1,476M | -¥577M | ¥153M |
| EPS | -¥1.39 | -¥6.99 | -¥2.73 | ¥0.73 |
| Operating Margin | -34.84% | -46.35% | -21.12% | -15.63% |
| Balance Sheet | ||||
| Total Assets | ¥50,187M | ¥49,999M | ¥48,547M | ¥49,081M |
| Total Equity | ¥42,101M | ¥40,752M | ¥39,575M | ¥39,622M |
| Total Liabilities | ¥8,086M | ¥9,247M | ¥8,972M | ¥9,459M |
| Cash | ¥7,801M | ¥5,155M | ¥6,824M | ¥8,991M |
| Interest-bearing Debt | ¥669M | ¥632M | ¥434M | ¥467M |
| Equity Ratio | 83.89% | 81.51% | 81.52% | 80.73% |
| D/E Ratio | 0.02 | 0.02 | 0.01 | 0.01 |
| Cash Flow | ||||
| Operating CF | -¥143M | -¥850M | -¥430M | ¥195M |
| Investing CF | ¥2,173M | -¥2,075M | ¥2,325M | ¥2,091M |
| Financing CF | ¥14M | ¥160M | -¥216M | -¥205M |
| Free CF | -¥652M | -¥1,074M | -¥735M | ¥177M |
| Efficiency | ||||
| ROE | -0.71% | -3.62% | -1.46% | 0.39% |
| ROA | -0.59% | -2.95% | -1.19% | 0.31% |
Latest IR Information
-
[CYBERDYNE] Change in Strategic Innovation Business Outsourcing Contract | July 2026
CYBERDYNE has increased the research and development expenses for its Strategic Innovation Creation Program to a total of 194 million yen from FY2024 to FY2027, with no change to the contract period, which will continue until March 2028. The revenue...
Read more -
【CYBERDYNE】Increase in commissioned research expenses and budget revision|July 2026
CYBERDYNE has announced an increase in the total commissioned research and development expenses under the Strategic Innovation Creation Program (SIP) to 1,891 million yen from 2023 to 2027, with an expected revenue of 369 million yen in 2026.
Read more -
June 29, 2026 - Matters Related to Controlling Shareholders, etc.
The controlling shareholder is Mr. Yoshiyuki Yamakami (including direct and combined holdings of 85.68%), with measures to prevent conflicts of interest implemented through resolutions by the Board of Directors in transactions with University of Tsukuba, NEDO, and other entities. Daily...
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥300
Rating Score: 2.50 (Based on 2 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains robotic equipment and systems for medical and welfare in Japan, the United States, Europe, the Middle East, Africa, and the Asia Pacific countries. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; Acoustic X, a high-speed light pulse LED array light source that enables real time photoacoustic imaging; and CYIN for living support, which is an interface that uses biological information that can be controlled voluntarily outside of muscle activities. It also provides Cybernics Treatment, a treatment that uses HAL to enhance and regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; Neuro HALFIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT at home for enhancement of physical functions. In addition, the company provides rescue support in disaster sites, and heavy labor support for factories and plants, as well as engages in the entertainment business. CYBERDYNE Inc. was incorporated in 2004 and is headquartered in Tsukuba, Japan.